Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | UTHR |
---|---|---|
09:32 ET | 3190 | 346.97 |
09:41 ET | 200 | 346.88 |
09:52 ET | 300 | 346.66 |
09:54 ET | 986 | 345.56 |
09:57 ET | 700 | 345.65 |
10:01 ET | 500 | 346.14 |
10:03 ET | 500 | 346.765 |
10:12 ET | 1351 | 347.21 |
10:14 ET | 300 | 346.725 |
10:15 ET | 300 | 346 |
10:19 ET | 503 | 344.155 |
10:21 ET | 667 | 345.075 |
10:24 ET | 100 | 345.89 |
10:26 ET | 100 | 346.11 |
10:30 ET | 200 | 347.23 |
10:32 ET | 149 | 347.85 |
10:33 ET | 300 | 347.61 |
10:35 ET | 300 | 347.91 |
10:37 ET | 116 | 347.844 |
10:39 ET | 300 | 347.96 |
10:42 ET | 100 | 348.01 |
10:44 ET | 100 | 347.84 |
10:46 ET | 1250 | 348.185 |
10:48 ET | 263 | 348.19 |
10:50 ET | 100 | 347.935 |
10:51 ET | 300 | 347.86 |
10:53 ET | 1828 | 348.11 |
10:55 ET | 200 | 347.95 |
10:57 ET | 300 | 348.53 |
11:00 ET | 200 | 349.06 |
11:08 ET | 1200 | 349.23 |
11:11 ET | 200 | 348.82 |
11:24 ET | 400 | 348.95 |
11:29 ET | 126 | 348.74 |
11:33 ET | 400 | 348.69 |
11:40 ET | 100 | 348.735 |
11:44 ET | 200 | 348.775 |
11:45 ET | 100 | 348.77 |
11:47 ET | 100 | 348.64 |
11:49 ET | 500 | 348.964 |
11:56 ET | 200 | 348.935 |
11:58 ET | 976 | 348.93 |
12:00 ET | 400 | 348.78 |
12:02 ET | 1015 | 348.86 |
12:03 ET | 989 | 348.19 |
12:12 ET | 400 | 348.82 |
12:14 ET | 328 | 348.85 |
12:20 ET | 333 | 348.89 |
12:21 ET | 100 | 349.28 |
12:23 ET | 200 | 349.31 |
12:27 ET | 700 | 349.47 |
12:34 ET | 400 | 349.56 |
12:39 ET | 500 | 349.72 |
12:43 ET | 975 | 349.28 |
12:45 ET | 100 | 349.61 |
12:50 ET | 100 | 349.5 |
12:52 ET | 100 | 349.64 |
12:59 ET | 100 | 349.87 |
01:01 ET | 305 | 349.965 |
01:03 ET | 100 | 349.72 |
01:06 ET | 300 | 349.72 |
01:08 ET | 1800 | 349.455 |
01:15 ET | 100 | 348.9 |
01:19 ET | 511 | 348.54 |
01:21 ET | 100 | 348.05 |
01:24 ET | 305 | 348.48 |
01:26 ET | 100 | 348.245 |
01:35 ET | 500 | 348.3 |
01:46 ET | 276 | 348.505 |
01:48 ET | 500 | 348.78 |
01:51 ET | 200 | 348.44 |
01:53 ET | 200 | 348.46 |
01:55 ET | 300 | 348.71 |
01:57 ET | 100 | 348.47 |
02:02 ET | 100 | 348.47 |
02:04 ET | 200 | 348.47 |
02:08 ET | 550 | 348.22 |
02:09 ET | 100 | 348.295 |
02:22 ET | 100 | 348.32 |
02:24 ET | 506 | 347.93 |
02:26 ET | 309 | 347.84 |
02:29 ET | 100 | 348.13 |
02:33 ET | 300 | 347.83 |
02:36 ET | 100 | 347.55 |
02:42 ET | 607 | 347.69 |
02:45 ET | 100 | 347.425 |
02:49 ET | 200 | 347.45 |
02:51 ET | 100 | 347.495 |
03:00 ET | 100 | 347.495 |
03:02 ET | 300 | 347.78 |
03:05 ET | 300 | 347.91 |
03:09 ET | 1400 | 347.79 |
03:12 ET | 200 | 347.78 |
03:18 ET | 200 | 348.23 |
03:20 ET | 100 | 348.11 |
03:21 ET | 500 | 348.62 |
03:27 ET | 200 | 348.885 |
03:30 ET | 1411 | 348.75 |
03:32 ET | 500 | 348.095 |
03:34 ET | 310 | 348.0619 |
03:38 ET | 700 | 348.1 |
03:39 ET | 432 | 348.09 |
03:41 ET | 731 | 347.975 |
03:43 ET | 400 | 347.71 |
03:45 ET | 647 | 348.225 |
03:48 ET | 1865 | 348.26 |
03:50 ET | 490 | 348.255 |
03:52 ET | 2687 | 348.23 |
03:54 ET | 300 | 347.96 |
03:56 ET | 240 | 348.43 |
03:57 ET | 400 | 348.03 |
03:59 ET | 49048 | 348.03 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
United Therapeutics Corp | 15.5B | 16.0x | +8.22% |
Biomarin Pharmaceutical Inc | 17.1B | 67.9x | --- |
Neurocrine Biosciences Inc | 15.4B | 46.1x | +62.04% |
Exact Sciences Corp | 11.0B | -62.1x | --- |
Medpace Holdings Inc | 12.1B | 36.8x | +35.10% |
Beigene Ltd | 21.2B | -38.2x | --- |
United Therapeutics Corporation is a pharmaceutical company. It markets and sells commercial therapies to treat pulmonary arterial hypertension (PAH): Tyvaso DPI (treprostinil) Inhalation Powder (Tyvaso DPI); Tyvaso (treprostinil) Inhalation Solution (nebulized Tyvaso), which includes the Tyvaso Inhalation System; Remodulin (treprostinil) Injection (Remodulin); Orenitram (treprostinil) Extended-Release Tablets (Orenitram); and Adcirca (tadalafil) Tablets (Adcirca). Tyvaso DPI and nebulized Tyvaso are also approved to treat pulmonary hypertension associated with interstitial lung disease (PH-ILD). It also markets and sells an oncology product, Unituxin (dinutuximab) Injection (Unituxin) for treatment of high-risk neuroblastoma, and the Remunity Pump for Remodulin (Remunity). Tyvaso DPI is a drug-device combination product that incorporates the dry powder formulation technology and Dreamboat inhalation device technology used in MannKind’s Afrezza (insulin human) Inhalation Powder.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $15.5B |
---|---|
Revenue (TTM) | $2.6B |
Shares Outstanding | 44.5M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.57 |
EPS | $21.75 |
Book Value | $127.23 |
P/E Ratio | 16.0x |
Price/Sales (TTM) | 5.9 |
Price/Cash Flow (TTM) | 13.7x |
Operating Margin | 48.28% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.